Mimedx (MDXG) Receivables - Other (2017 - 2021)

Mimedx (MDXG) has 5 years of Receivables - Other data on file, last reported at $400000.0 in Q2 2021.

• For the quarter ending Q2 2021, Receivables - Other changed N/A year-over-year to $400000.0; the trailing twelve-month figure through Jun 2021 stood at $400000.0 (changed N/A YoY), and the FY2020 full-year result was $200000.0, down 84.62% from the prior year.
• Receivables - Other fell to $400000.0 in Q2 2021, from $700000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $5.9 million in Q4 2017 to a low of $200000.0 in Q4 2020.
• A 5-year average of $2.0 million and a median of $1.0 million in 2019 frame the typical range for Receivables - Other.
• Across the five-year window, Receivables - Other slumped 84.62% in 2020 and grew 16.67% in 2021, its largest moves.
• Tracing MDXG's Receivables - Other over 5 years: stood at $5.9 million in 2017, then decreased by 27.12% to $4.3 million in 2018, then slumped by 69.77% to $1.3 million in 2019, then tumbled by 84.62% to $200000.0 in 2020, then surged by 100.0% to $400000.0 in 2021.
• Business Quant data shows MDXG's Receivables - Other at $400000.0 in Q2 2021, $700000.0 in Q1 2021, and $200000.0 in Q4 2020.